Company Filing History:
Years Active: 2013-2014
Title: Albert Antolin Hernandez: Innovator in Pharmaceutical Compounds
Introduction
Albert Antolin Hernandez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target specific enzyme-associated disorders. With a total of 2 patents to his name, his work is paving the way for innovative treatments.
Latest Patents
Hernandez's latest patents focus on inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1. These compounds, derived from perhydroquinoline and perhydroisoquinoline, serve as active pharmaceutical ingredients. They are particularly useful for the prophylaxis or treatment of various diseases associated with the 11-beta-HSD1 enzyme, including glaucoma, metabolic disorders, obesity, and cognitive disorders such as Alzheimer's disease.
Career Highlights
Albert Antolin Hernandez is currently employed at Laboratorios Salvat, S.A. His work at this esteemed company has allowed him to explore and develop innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Hernandez collaborates with talented professionals in his field, including Juan Lorenzo Catena Ruiz and Carme Serra Comas. These collaborations enhance the quality and impact of his research, fostering an environment of innovation and discovery.
Conclusion
Albert Antolin Hernandez is a distinguished inventor whose work in pharmaceutical compounds is making a significant impact on the treatment of various diseases. His innovative approach and dedication to research continue to inspire advancements in the field.